Adrenomedullin inhibits angiotensin AT1A receptor expression and function in cardiac fibroblasts

Regulatory Peptides

Volumn 112, Issue 1-3, 2003, Pages 131-137

  Autelitano, Dominic J ^a,b   Ridings, Rebecca ^a   Pipolo, Luisa ^a   Thomas, Walter G ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Cryptome Research Pty Ltd   (Australia)

Author keywords

cAMP; Collagen; Remodelling

Indexed keywords

ADRENOMEDULLIN; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; COLLAGEN; CYCLIC AMP; FORSKOLIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL FUNCTION; COLLAGEN SYNTHESIS; DOWN REGULATION; FIBROBLAST; HEART MUSCLE CELL; HORMONE ACTION; INCUBATION TIME; MOLECULAR INTERACTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 0037445816     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00031-4     Document Type: Article

References (30)

1. Kitamura K., Kangawa K., Matsuo H., Eto T. Adrenomedullin: implications for hypertension research. Drugs. 49:1995;485-495.
2. Hinson J.P., Kapas S., Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21:2000;138-167.
3. Caron K.M., Smithies O. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc. Natl. Acad. Sci. U. S. A. 98:2001;615-619.
4. Shindo T., Kurihara Y., Nishimatsu H., Moriyama N., Kakoki M., Wang Y.et al. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation. 104:2001;1964-1971.
5. Jougasaki M., Wei C.-M., McKinley L.J., Burnett J.C. Jr. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation. 92:1995;286-289.
6. Owji A.A., Smith D.M., Coppock H.A., Morgan D.G.A., Bhogal R., Ghatei M.A.et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 136:1995;2127-2134.
7. Sato A., Autelitano D.J. Adrenomedullin induces expression of c-fos and AP-1 activity in rat vascular smooth muscle cells and cardiomyocytes. Biochem. Biophys. Res. Commun. 217:1995;211-216.
8. Sato A., Canny B.J., Autelitano D.J. Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes. Biochem. Biophys. Res. Commun. 230:1997;311-314.
9. Nishikimi T., Horio T., Yoshihara F., Nagaya N., Matsuo H., Kangawa K. Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes. Eur. J. Pharmacol. 353:1998;337-344.
10. Tsuruda T., Kato J., Kitamura K., Kuwasako K., Imamura T., Koiwaya Y.et al. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension. 31:1998;505-510.
11. Autelitano D.J., Ridings R., Tang F. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro. Cardiovasc. Res. 51:2001;255-264.
12. Horio T., Nishikimi T., Yoshihara F., Matsuo H., Takishita S., Kangawa K. Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts. Eur. J. Pharmacol. 382:1999;1-9.
13. Tsuruda T., Kato J., Kitamura K., Kawamoto M., Kuwasako K., Imamura T.et al. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. Cardiovasc. Res. 43:1999;958-967.
14. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ. Res. 73:1993;413-423.
15. Schorb W., Booz G.W., Dostal D.E., Conrad K.M., Chang K.C., Baker K.M. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ. Res. 72:1993;1245-1254.
16. Villarreal F.J., Kim N.N., Ungab G.D., Printz M.P., Dillmann W.H. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation. 88:1993;2849-2861.
17. Crabos M., Roth M., Hahn A.W., Erne P. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J. Clin. Invest. 93:1994;2372-2378.
18. Charles C.J., Rademaker M.T., Richards A.M., Cooper G.J., Coy D.H., Nicholls M.G. Adrenomedullin attenuates pressor response to angiotensin II in conscious sheep. J. Cardiovasc. Pharmacol. 36:2000;526-532.
19. Troughton R.W., Frampton C.M., Lewis L.K., Yandle T.G., Richards A.M., Nicholls M.G. Differing thresholds for modulatory effects of adrenomedullin infusion on haemodynamic and hormone responses to angiotensin II and adrenocorticotrophic hormone in healthy volunteers. Clin. Sci. (London). 101:2001;103-109.
20. Luodonpaa M., Vuolteenaho O., Eskelinen S., Ruskoaho H. Effects of adrenomedullin on hypertrophic responses induced by angiotensin II, endothelin-1 and phenylephrine. Peptides. 22:2001;1859-1866.
21. Qian H., Pipolo L., Thomas W.G. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization. Mol. Endocrinol. 15:2001;1706-1719.
22. Autelitano D.J., Ridings R. Adrenomedullin signalling in cardiomyocytes is dependent upon CRLR and RAMP2 expression. Peptides. 22:2001;1851-1857.
23. Wang X., Nickenig G., Murphy T.J. The vascular smooth muscle type I angiotensin II receptor mRNA is destabilized by cyclic AMP-elevating agents. Mol. Pharmacol. 52:1997;781-787.
24. Xu K., Murphy T.J. Reconstitution of angiotensin receptor mRNA down-regulation in vascular smooth muscle. Post-transcriptional control by protein kinase A but not mitogenic signaling directed by the 5′-untranslated region. J. Biol. Chem. 275:2000;7604-7611.
25. Wang X., Murphy T.J. Inhibition of cyclic AMP-dependent kinase by expression of a protein kinase inhibitor/enhanced green fluorescent fusion protein attenuates angiotensin II-induced type 1 AT1 receptor mRNA down-regulation in vascular smooth muscle cells. Mol. Pharmacol. 54:1998;514-524.
26. Makita N., Iwai N., Inagami T., Badr K.F. Two distinct pathways in the down-regulation of type-1 angiotension II receptor gene in rat glomerular mesangial cells. Biochem. Biophys. Res. Commun. 185:1992;142-146.
27. Cheng H.F., Becker B.N., Burns K.D., Harris R.C. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J. Clin. Invest. 95:1995;2012-2019.
28. Thomas W.G., Brandenburger Y., Autelitano D.J., Pham T., Qian H., Hannan R.D. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ. Res. 90:2002;135-142.
29. Dobrzynski E., Wang C., Chao J., Chao L. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 36:2000;995-1001.
30. Charles C.J., Nicholls M.G., Rademaker M.T., Richards A.M. Comparative actions of adrenomedullin and nitroprusside: interactions with ANG II and norepinephrine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:2001;R1887-R1894.